Dx dialogues: the impact of next-generation sequencing on clinical utility
Sanjay Juneja, MD, talks through the impact of next-generation sequencing in both somatic and germline testing.
Up Next
Dx dialogues: the importance of comprehensive testing in oncology
Dx dialogues: why staying current with technology is critical in oncology
Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML
Dx dialogues: using molecular profiling to identify mutations in R/R AML
Dx dialogues: changes in treatment sequencing for metastatic breast cancer
Dx dialogues: advancements in treating indolent systemic mastocytosis
Dx dialogues: a potential paradigm shift in the treatment of metastatic breast cancer
Dx dialogues: other potential treatments for indolent systemic mastocytosis
Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Dx dialogues: diagnosing indolent systemic mastocytosis
